Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data. [electronic resource]
Producer: 20120606Description: 6 p. digitalISSN:- 1475-2840
- Adamantane -- adverse effects
- Cardiovascular Diseases -- etiology
- Clinical Trials as Topic
- Diabetes Complications -- etiology
- Diabetes Mellitus, Type 2 -- complications
- Dipeptides -- adverse effects
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Drug Therapy, Combination
- Evidence-Based Medicine
- Humans
- Patient Safety
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.